Lhasa Limited hosts and attends events throughout the year. Details of specific events are available below.
2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab
24 June 2021, Online
We are delighted to have Andrew Teasdale PhD presenting within this webinar; Why you should consider controlling your potentially mutagenic impurities outside the lab.
Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).
18 May 2021
19 May 2021